These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17266885)
1. [Budget impact analysis of a blood saving program for urgent traumatological surgery]. Izuel Rami M; Gómez Barrera M; Villar Fernández I; Rabanaque Hernández MJ; Cuenca Espiérrez J; García-Erce JA Med Clin (Barc); 2007 Jan; 128(1):7-11. PubMed ID: 17266885 [TBL] [Abstract][Full Text] [Related]
2. Blood conservation in the critically ill. Thomas J; Martinez A Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S11-8. PubMed ID: 17687066 [TBL] [Abstract][Full Text] [Related]
3. [Perioperative anaemia in geriatric patients with hip fracture]. Izuel-Rami M; Cuenca Espiérrez J; García-Erce JA; Gómez-Barrera M; Carcelén Andrés J; Rabanaque Hernández MJ Farm Hosp; 2005; 29(4):250-7. PubMed ID: 16268741 [TBL] [Abstract][Full Text] [Related]
4. The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. Rowlands M; Forward DP; Sahota O; Moppett IK Trials; 2013 Sep; 14():288. PubMed ID: 24015990 [TBL] [Abstract][Full Text] [Related]
5. [Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly]. Cuenca Espiérrez J; García Erce JA; Martínez Martín AA; Solano VM; Modrego Aranda FJ Med Clin (Barc); 2004 Sep; 123(8):281-5. PubMed ID: 15373973 [TBL] [Abstract][Full Text] [Related]
6. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Henry DH; Dahl NV; Auerbach M; Tchekmedyian S; Laufman LR Oncologist; 2007 Feb; 12(2):231-42. PubMed ID: 17296819 [TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. Reed SD; Radeva JI; Daniel DB; Mody SH; Forlenza JB; McKenzie RS; Schulman KA Pharmacoeconomics; 2006; 24(5):479-94. PubMed ID: 16706573 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietic agents for anemia of critical illness. Shermock KM; Horn E; Rice TL Am J Health Syst Pharm; 2008 Mar; 65(6):540-6. PubMed ID: 18319499 [TBL] [Abstract][Full Text] [Related]
9. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Cuenca J; García-Erce JA; Martínez AA; Solano VM; Molina J; Muñoz M Arch Orthop Trauma Surg; 2005 Jun; 125(5):342-7. PubMed ID: 15789233 [TBL] [Abstract][Full Text] [Related]
10. Epoetin alfa protocol and multidisciplinary blood-conservation program for critically ill patients. Pell LJ; Martin BS; Shirk MB Am J Health Syst Pharm; 2005 Feb; 62(4):400-5. PubMed ID: 15745893 [TBL] [Abstract][Full Text] [Related]
11. What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis. Ortega A; Dranitsaris G; Puodziunas AL Cancer; 1998 Dec; 83(12):2588-96. PubMed ID: 9874467 [TBL] [Abstract][Full Text] [Related]
12. Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy. Meadowcroft AM; Gilbert CJ; Maravich-May D; Hayward SL Am J Health Syst Pharm; 1998 Sep; 55(18):1898-902. PubMed ID: 9784769 [TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer. Martin SC; Gagnon DD; Zhang L; Bokemeyer C; Van Marwijk Kooy M; van Hout B Pharmacoeconomics; 2003; 21(16):1153-69. PubMed ID: 14594437 [TBL] [Abstract][Full Text] [Related]
14. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Bodemar G; Kechagias S; Almer S; Danielson BG Scand J Gastroenterol; 2004 May; 39(5):454-8. PubMed ID: 15180183 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness impact of iron dextran on hemodialysis patients' use of epoetin alfa and blood. Driver PS Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S12-6. PubMed ID: 9872688 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with successful epoetin alfa therapy in premature infants. Reiter PD; Rosenberg AA; Valuck RJ Ann Pharmacother; 2000 Apr; 34(4):433-9. PubMed ID: 10772426 [TBL] [Abstract][Full Text] [Related]
17. Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia. Suffredini DA; Xu W; Sun J; Barea-Mendoza J; Solomon SB; Brashears SL; Perlegas A; Kim-Shapiro DB; Klein HG; Natanson C; Cortés-Puch I Transfusion; 2017 Oct; 57(10):2338-2347. PubMed ID: 28656646 [TBL] [Abstract][Full Text] [Related]
18. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P; Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591 [TBL] [Abstract][Full Text] [Related]
19. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. García-Erce JA; Cuenca J; Muñoz M; Izuel M; Martínez AA; Herrera A; Solano VM; Martínez F Vox Sang; 2005 May; 88(4):235-43. PubMed ID: 15877644 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. García-Erce JA; Cuenca J; Haman-Alcober S; Martínez AA; Herrera A; Muñoz M Vox Sang; 2009 Oct; 97(3):260-7. PubMed ID: 19497085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]